# REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

> **NCT04276558** · PHASE2 · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 108 (actual)

## Conditions studied

- Neurotrophic Keratitis

## Interventions

- **DRUG:** Udonitrectag
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT04276558
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-13
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-04-29
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04276558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04276558, "REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04276558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*